Uncharacterized Protein, Uncharacterized
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Related structures:
AlphaFold database: A4IA70
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 153 | 155 | PF00675 | 0.633 |
CLV_NRD_NRD_1 | 263 | 265 | PF00675 | 0.403 |
CLV_NRD_NRD_1 | 36 | 38 | PF00675 | 0.505 |
CLV_NRD_NRD_1 | 51 | 53 | PF00675 | 0.613 |
CLV_NRD_NRD_1 | 9 | 11 | PF00675 | 0.734 |
CLV_PCSK_KEX2_1 | 120 | 122 | PF00082 | 0.666 |
CLV_PCSK_KEX2_1 | 151 | 153 | PF00082 | 0.650 |
CLV_PCSK_KEX2_1 | 265 | 267 | PF00082 | 0.533 |
CLV_PCSK_KEX2_1 | 35 | 37 | PF00082 | 0.521 |
CLV_PCSK_KEX2_1 | 51 | 53 | PF00082 | 0.620 |
CLV_PCSK_KEX2_1 | 9 | 11 | PF00082 | 0.734 |
CLV_PCSK_PC1ET2_1 | 120 | 122 | PF00082 | 0.687 |
CLV_PCSK_PC1ET2_1 | 151 | 153 | PF00082 | 0.670 |
CLV_PCSK_PC1ET2_1 | 265 | 267 | PF00082 | 0.533 |
CLV_PCSK_SKI1_1 | 191 | 195 | PF00082 | 0.528 |
CLV_PCSK_SKI1_1 | 41 | 45 | PF00082 | 0.641 |
DOC_MAPK_MEF2A_6 | 131 | 138 | PF00069 | 0.446 |
DOC_PP4_FxxP_1 | 65 | 68 | PF00568 | 0.672 |
DOC_USP7_MATH_1 | 115 | 119 | PF00917 | 0.625 |
DOC_USP7_MATH_1 | 226 | 230 | PF00917 | 0.547 |
DOC_USP7_MATH_1 | 289 | 293 | PF00917 | 0.733 |
DOC_WW_Pin1_4 | 284 | 289 | PF00397 | 0.723 |
LIG_14-3-3_CanoR_1 | 114 | 124 | PF00244 | 0.612 |
LIG_14-3-3_CanoR_1 | 280 | 285 | PF00244 | 0.718 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.661 |
LIG_BRCT_BRCA1_1 | 275 | 279 | PF00533 | 0.581 |
LIG_BRCT_BRCA1_1 | 280 | 284 | PF00533 | 0.688 |
LIG_FHA_1 | 192 | 198 | PF00498 | 0.664 |
LIG_FHA_1 | 27 | 33 | PF00498 | 0.591 |
LIG_FHA_1 | 92 | 98 | PF00498 | 0.631 |
LIG_FHA_2 | 160 | 166 | PF00498 | 0.700 |
LIG_FHA_2 | 56 | 62 | PF00498 | 0.658 |
LIG_IBAR_NPY_1 | 273 | 275 | PF08397 | 0.563 |
LIG_LIR_Apic_2 | 198 | 204 | PF02991 | 0.556 |
LIG_LIR_Gen_1 | 94 | 104 | PF02991 | 0.651 |
LIG_LIR_Nem_3 | 20 | 26 | PF02991 | 0.489 |
LIG_LIR_Nem_3 | 249 | 254 | PF02991 | 0.486 |
LIG_LIR_Nem_3 | 74 | 80 | PF02991 | 0.629 |
LIG_PDZ_Class_1 | 289 | 294 | PF00595 | 0.524 |
LIG_SH2_CRK | 205 | 209 | PF00017 | 0.554 |
LIG_SH2_CRK | 275 | 279 | PF00017 | 0.607 |
LIG_SH2_NCK_1 | 275 | 279 | PF00017 | 0.607 |
LIG_SH2_PTP2 | 201 | 204 | PF00017 | 0.540 |
LIG_SH2_STAP1 | 275 | 279 | PF00017 | 0.581 |
LIG_SH2_STAT3 | 234 | 237 | PF00017 | 0.637 |
LIG_SH2_STAT5 | 201 | 204 | PF00017 | 0.561 |
LIG_SH3_3 | 21 | 27 | PF00018 | 0.587 |
LIG_SUMO_SIM_par_1 | 255 | 260 | PF11976 | 0.580 |
LIG_TYR_ITSM | 73 | 80 | PF00017 | 0.713 |
LIG_WW_3 | 287 | 291 | PF00397 | 0.644 |
MOD_CDK_SPxK_1 | 284 | 290 | PF00069 | 0.651 |
MOD_CK2_1 | 159 | 165 | PF00069 | 0.701 |
MOD_CK2_1 | 210 | 216 | PF00069 | 0.553 |
MOD_CK2_1 | 55 | 61 | PF00069 | 0.655 |
MOD_Cter_Amidation | 49 | 52 | PF01082 | 0.694 |
MOD_Cter_Amidation | 7 | 10 | PF01082 | 0.657 |
MOD_GlcNHglycan | 197 | 200 | PF01048 | 0.698 |
MOD_GSK3_1 | 116 | 123 | PF00069 | 0.634 |
MOD_GSK3_1 | 134 | 141 | PF00069 | 0.555 |
MOD_GSK3_1 | 191 | 198 | PF00069 | 0.670 |
MOD_GSK3_1 | 26 | 33 | PF00069 | 0.583 |
MOD_GSK3_1 | 274 | 281 | PF00069 | 0.574 |
MOD_GSK3_1 | 284 | 291 | PF00069 | 0.701 |
MOD_GSK3_1 | 87 | 94 | PF00069 | 0.600 |
MOD_N-GLC_1 | 211 | 216 | PF02516 | 0.552 |
MOD_N-GLC_1 | 70 | 75 | PF02516 | 0.642 |
MOD_NEK2_1 | 138 | 143 | PF00069 | 0.585 |
MOD_NEK2_1 | 233 | 238 | PF00069 | 0.520 |
MOD_NEK2_1 | 243 | 248 | PF00069 | 0.423 |
MOD_NEK2_1 | 279 | 284 | PF00069 | 0.712 |
MOD_NEK2_1 | 70 | 75 | PF00069 | 0.693 |
MOD_NEK2_1 | 99 | 104 | PF00069 | 0.646 |
MOD_NEK2_2 | 274 | 279 | PF00069 | 0.584 |
MOD_PIKK_1 | 233 | 239 | PF00454 | 0.611 |
MOD_PKA_1 | 120 | 126 | PF00069 | 0.609 |
MOD_PKA_2 | 120 | 126 | PF00069 | 0.650 |
MOD_PKA_2 | 195 | 201 | PF00069 | 0.694 |
MOD_PKA_2 | 279 | 285 | PF00069 | 0.589 |
MOD_Plk_1 | 211 | 217 | PF00069 | 0.515 |
MOD_Plk_4 | 134 | 140 | PF00069 | 0.565 |
MOD_Plk_4 | 226 | 232 | PF00069 | 0.596 |
MOD_Plk_4 | 274 | 280 | PF00069 | 0.591 |
MOD_Plk_4 | 99 | 105 | PF00069 | 0.643 |
MOD_ProDKin_1 | 284 | 290 | PF00069 | 0.725 |
MOD_SUMO_rev_2 | 178 | 185 | PF00179 | 0.653 |
MOD_SUMO_rev_2 | 268 | 272 | PF00179 | 0.540 |
TRG_DiLeu_BaEn_2 | 37 | 43 | PF01217 | 0.646 |
TRG_ENDOCYTIC_2 | 205 | 208 | PF00928 | 0.589 |
TRG_ENDOCYTIC_2 | 275 | 278 | PF00928 | 0.602 |
TRG_ENDOCYTIC_2 | 77 | 80 | PF00928 | 0.656 |
TRG_ER_diArg_1 | 152 | 154 | PF00400 | 0.658 |
TRG_ER_diArg_1 | 263 | 266 | PF00400 | 0.402 |
TRG_ER_diArg_1 | 34 | 37 | PF00400 | 0.511 |
TRG_ER_diArg_1 | 9 | 11 | PF00400 | 0.733 |
TRG_Pf-PMV_PEXEL_1 | 41 | 46 | PF00026 | 0.666 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PAU8 | Leptomonas seymouri | 59% | 100% |
A0A0S4IYA0 | Bodo saltans | 24% | 100% |
A0A1X0PA38 | Trypanosomatidae | 29% | 100% |
A0A3Q8ILA3 | Leishmania donovani | 100% | 96% |
A0A3R7KSA4 | Trypanosoma rangeli | 31% | 100% |
A4HB13 | Leishmania braziliensis | 73% | 100% |
C9ZM36 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 26% | 100% |
E9B583 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 91% | 100% |
Q4Q2Q0 | Leishmania major | 91% | 100% |
V5BV16 | Trypanosoma cruzi | 31% | 100% |